Cell and Gene Therapy Catapult forms consortium of over 20 organisations
Consortium will assess multiple process analytical technologies used in the cell and gene therapy industry
Read More
Tag: Cell and Gene Therapy Catapult
UK sees a 20% growth in the number of advanced therapy trials, report finds
Cell and Gene Therapy Catapult report also found a surge in the number of commercially sponsored trials
Read More
UK surge in cell and gene therapy trials
A surge in cell and gene therapy trials – an increase of 37% since 2017 – highlights the UK’s leading position as a developmental hub in the sector, says the Cell and Gene Therapy Catapult.
Read More
UK’s cell and gene therapy industry continues to strengthen
The UK’s cell and gene therapy industry has seen a 60% increase in manufacturing space in the last year, new research published by the Cell and Gene Therapy (CGT) Catapult has revealed.
Read More
Cell and Gene Therapy Catapult forges stronger link with Japan
The UK’s Cell and Gene Therapy Catapult (CGT Catapult) is linking with the Japanese Society for Regenerative Medicine (JSRM) to propel progress in regenerative medicine and cell/gene therapies in both countries.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
